Purchase Order 75A50121P00004
Award Date
11/16/20
Potential Completion Date
11/22/21
Potential Value
$12M
Awardee
PPD Development LP
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $126,485,055.00 definitive time and materials contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract is for advanced research and development activities to support BARDA's continuing efforts on COVID-19 vaccine development, assessing the impact of variants on vaccine immunogenicity, and analyzing novel immunogenicity...
This is a cost-plus-fixed-fee definitive contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization (CRO), for R&D services related to biomedical basic research. The $27,437,431.92 contract has a performance period ending on October 31, 2021 and is not set aside for any specific business type. PPD Development LP has been awarded over $500 million in prime federal...
This is a $222,126,308 cost-plus-incentive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to PPD Development LP, a global contract research organization (CRO). The contract supports a randomized, double-blind, placebo-controlled, multicenter Phase 2 clinical trial in the U.S. to evaluate the safety and efficacy of novel host-directed therapeutic candidates in hospitalized adults with acute respiratory distress syndrome (ARDS). The contract has an...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to PPD Development LP, a global contract research organization (CRO). The contract, valued at $64,031,927.00, is for completing the ACTIV 2 study to support COVID-19 research. The contract is a cost-plus-fixed-fee type and does not have a set-aside designation. PPD Development LP is a subsidiary of Thermo Fisher...
This is a delivery order under the Medical Countermeasures Clinical Studies Network contract vehicle, awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to PPD Development, LP, a global contract research organization (CRO). The $6,186,155.39 delivery order is for a H5N1 clinical study, under a cost-plus-fixed-fee contract type. PPD Development, LP has been awarded over $500 million in prime federal contracts and participated as a subcontractor on grants and...
This is a $75,173,993.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract provides comprehensive and rapid response services for NIAID's research programs related to HIV and other infectious diseases. This order falls under a larger $545 million Comprehensive and Rapid Response contract vehicle that...
This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, valued at $66,339,562.95, is for the TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER and has a performance period ending on February 23, 2023. PPD Development LP, a subsidiary of Thermo Fisher...
This is a $5,758,524.34 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to PPD Development LP, a global contract research organization (CRO). The contract is to provide monitoring services for a Phase III clinical trial, specifically trial A5300B/PHOENIX. It is a cost-plus-fixed-fee contract with an ultimate completion date of December 14, 2025. The contract was awarded on April 15, 2019 and is not...
This is a $16,382,387.80 cost-plus-fixed-fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to PPD Development, LP. The contract is for clinical services described in Tasks 1 through 15 under the ASPR-16-05933 requirement, which is part of the Medical Countermeasures Clinical Studies Network IDIQ contract vehicle. The contract is for a Heterologous Prime Boost Influenza Vaccine Trial and does not have a set-aside...
This is a federal contract award to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The $151,299.72 firm fixed-price delivery order was issued under the Medical Product Research and Development Indefinite Delivery Vehicle (IDV) with the U.S. Army Medical Command (MEDCOM). The contract does not have a set-aside designation. PPD Development LP provides comprehensive clinical trial and research support services to various federal...